The main cancer therapy targets are tubulin protein, cyclin-dependent kinases (CIKs), epidermal growth factor receptor (EGFR), Ras protein, and, in recent years, cancer stem cells (CSC) [7,8]. Here, TRAF3IP2 is linked to cancer.